European Patent Office

T 1315/13 (Cancer biomarker Cyr61/CHILDREN'S MEDICAL CENTER CORPORATION) of 29.05.2018

European Case Law Identifier
ECLI:EP:BA:2018:T131513.20180529
Date of decision
29 May 2018
Case number
T 1315/13
Petition for review of
-
Application number
06735465.4
IPC class
G01N 33/53
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
CYR61 AS A BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF CANCERS OF EPITHELIAL ORIGIN
Applicant name
CHILDREN'S MEDICAL CENTER CORPORATION
Opponent name
-
Board
3.3.01
Headnote
-
Relevant legal provisions
European Patent Convention Art 54(2)Rules of procedure of the Boards of Appeal Art 15(3)
Keywords
Oral proceedings - held in absence of appellant
Novelty - (no)
Admission of requests for which claims were not formulated - (no)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed.